Clinical Trial Update: Stellate Ganglion Blockade for Refractory Chronic Migraine [NA]

View source ↗

Summary

A clinical trial evaluating stellate ganglion blockade for refractory chronic migraine has completed. The study was sponsored by Ankara City Hospital Bilkent an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Ankara City Hospital Bilkent | Conditions: Headache, Migraine, Chronic Migraine Headache | NA | Status: COMPLETED